Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	EPHB2 MRC1 OR8I2 CYSLTR2 OR10J3 DDR2 FGFRL1 KIR2DS2 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 NRXN3 OR13A1 CD79A LTBP1 KIR2DL3 GPR132 ALK OR5F1 AGTRAP	3.37e-07	1353	152	29	GO:0004888
GeneOntologyMolecularFunction	olfactory receptor activity	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 OR13A1 OR5F1	5.60e-06	431	152	14	GO:0004984
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1 AGTRAP	4.36e-05	884	152	19	GO:0004930
GeneOntologyMolecularFunction	odorant binding	OR8I2 OR10J3 OR5AR1 OR10R2 OR10J1 OR13A1 OR5F1	5.37e-05	127	152	7	GO:0005549
GeneOntologyBiologicalProcess	sensory perception	OR8I2 COMT PDE6B OR10J3 OR2T10 BTBD9 TECTA OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 ABLIM1 OR10J5 SLC24A4 TIMP3 CNTN5 OR13A1 SLC45A2 TRPM1 USH2A OR5F1	3.82e-07	1072	154	25	GO:0007600
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception of smell	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	8.89e-07	432	154	15	GO:0050911
GeneOntologyBiologicalProcess	response to angiotensin	COMT DDR2 PRKCD PRKD1 MAP3K7 AGTRAP	1.90e-06	50	154	6	GO:1990776
GeneOntologyBiologicalProcess	sensory perception of smell	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	2.21e-06	465	154	15	GO:0007608
GeneOntologyBiologicalProcess	detection of chemical stimulus involved in sensory perception	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	3.70e-06	485	154	15	GO:0050907
GeneOntologyBiologicalProcess	detection of stimulus involved in sensory perception	OR8I2 COMT OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	7.70e-06	582	154	16	GO:0050906
GeneOntologyBiologicalProcess	detection of stimulus	OR8I2 COMT PDE6B OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 ANO3 OR5F1	7.76e-06	722	154	18	GO:0051606
GeneOntologyBiologicalProcess	detection of chemical stimulus	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	9.34e-06	524	154	15	GO:0009593
GeneOntologyBiologicalProcess	cellular response to angiotensin	DDR2 PRKCD PRKD1 MAP3K7 AGTRAP	1.16e-05	40	154	5	GO:1904385
GeneOntologyBiologicalProcess	G protein-coupled receptor signaling pathway	OR8I2 CYSLTR2 ABL1 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 RIT2 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 SLC24A4 OR13A1 LRP1 PRKD1 TRPM1 GPR132 ALK OR5F1 AGTRAP	1.34e-05	1395	154	26	GO:0007186
GeneOntologyBiologicalProcess	sensory perception of chemical stimulus	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 SLC24A4 OR13A1 OR5F1	1.55e-05	547	154	15	GO:0007606
GeneOntologyBiologicalProcess	negative regulation of intracellular signal transduction	EPHB2 IL10 ABL1 SESN3 F2RL1 SESN1 HDAC3 FBLN1 CSNK1A1L SLC24A4 CSNK1A1 LRP1 CPNE1 PRKCD RABGEF1 RUBCN ALG13	9.59e-05	795	154	17	GO:1902532
GeneOntologyBiologicalProcess	regulation of TORC1 signaling	SESN3 SESN1 CSNK1A1L CSNK1A1 USP32 ALG13	1.17e-04	102	154	6	GO:1903432
GeneOntologyBiologicalProcess	Fc receptor mediated stimulatory signaling pathway	ABL1 PRKCD RABGEF1 VAV3	1.31e-04	35	154	4	GO:0002431
GeneOntologyBiologicalProcess	TORC1 signaling	SESN3 SESN1 CSNK1A1L CSNK1A1 USP32 ALG13	1.69e-04	109	154	6	GO:0038202
GeneOntologyBiologicalProcess	regulation of TOR signaling	SESN3 SESN1 HDAC3 CSNK1A1L CSNK1A1 USP32 ALG13	1.88e-04	158	154	7	GO:0032006
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	EPHB2 ABL1 RASGRF2 DOCK9 F2RL1 RIT2 RIT1 CSNK1A1L CSNK1A1 RABGEF1 VAV3 ULK1 YWHAQ	2.06e-04	538	154	13	GO:0007264
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	ABL1 KIR2DS2 BCL2A1 F2RL1 CSNK1A1L CSNK1A1 PRKCD CD79A RABGEF1 PRKD1 VAV3 KIR2DL2 KIR2DL3 MAP3K7	2.16e-04	615	154	14	GO:0002764
GeneOntologyBiologicalProcess	neuron development	EPHB2 PRTG ABL1 TOX DDR2 DVL3 LAMB1 BRINP1 TECTA TTC3 B4GALT6 RIT2 EFHC2 ABLIM1 PTPN9 NRXN3 CNTN5 LRP1 CPNE1 PRKD1 TRPM1 ULK1 ALK ANKS1A	2.18e-04	1463	154	24	GO:0048666
Domain	Olfact_rcpt	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 OR13A1 OR5F1	4.83e-06	393	154	14	IPR000725
Domain	GPCR_Rhodpsn_7TM	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1	1.07e-05	670	154	18	IPR017452
Domain	7tm_1	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1	1.23e-05	677	154	18	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1	1.44e-05	685	154	18	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1	1.62e-05	691	154	18	PS50262
Domain	GPCR_Rhodpsn	OR8I2 CYSLTR2 OR10J3 OR2T10 OR2T11 F2RL1 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 GPR161 OR10J5 OR13A1 GPR132 OR5F1	1.65e-05	692	154	18	IPR000276
Domain	ASX_HYDROXYL	SVEP1 FBLN1 NRXN3 VCAN LRP1 LTBP1	1.80e-04	100	154	6	PS00010
Domain	Sestrin	SESN3 SESN1	2.02e-04	3	154	2	IPR006730
Domain	AhpD-like	SESN3 SESN1	2.02e-04	3	154	2	IPR029032
Domain	PA26	SESN3 SESN1	2.02e-04	3	154	2	PF04636
Domain	-	SESN3 SESN1	2.02e-04	3	154	2	1.20.1290.10
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 FBLN1 NRXN3 VCAN LRP1 LTBP1	2.47e-04	106	154	6	IPR000152
Domain	TRPM_tetra	TRPM3 TRPM1	4.01e-04	4	154	2	PF16519
Domain	TRPM_tetra	TRPM3 TRPM1	4.01e-04	4	154	2	IPR032415
Domain	MFS_1	SLC37A1 SLC16A12 SLC18A1 SLC16A14 SLC45A2	4.38e-04	77	154	5	PF07690
Domain	MFS	SLC37A1 SLC16A12 SLC18A1 SLC16A14 SLC45A2	4.38e-04	77	154	5	IPR011701
Domain	EGF	TECTA SVEP1 NRXN3 VCAN LRP1 LTBP1	6.23e-04	126	154	6	PF00008
Domain	Pkinase_Tyr	EPHB2 ABL1 DDR2 HASPIN MAP3K7 ALK	7.05e-04	129	154	6	PF07714
Domain	EGF	LAMB1 TECTA SVEP1 FBLN1 NRXN3 VCAN LRP1 LTBP1	7.53e-04	235	154	8	SM00181
Domain	MFS_dom	SLC37A1 SLC16A12 SLC18A1 SLC16A14 SLC45A2 SLC2A11	8.60e-04	134	154	6	IPR020846
Pathway	KEGG_OLFACTORY_TRANSDUCTION	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 OR13A1 OR5F1	8.93e-06	389	125	14	M14091
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 OR13A1 OR5F1	1.95e-05	417	125	14	M4072
Pubmed	Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	9.20e-08	3	158	3	22960345
Pubmed	Imputation of KIR Types from SNP Variation Data.	KIR2DS2 KIR2DL2 KIR2DL3	9.20e-08	3	158	3	26430804
Pubmed	Cutting edge: selective expression of inhibitory or activating killer cell Ig-like receptors in circulating CD4+ T lymphocytes.	KIR2DS2 KIR2DL2 KIR2DL3	9.20e-08	3	158	3	18292496
Pubmed	Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.	KIR2DS2 KIR2DL2 KIR2DL3	9.20e-08	3	158	3	30696053
Pubmed	The human olfactory receptor gene family.	OR8I2 OR10J3 OR2T10 OR2T11 OR5AR1 OR10R2 OR10J1 OR52N1 OR1N2 OR1L8 OR6F1 OR10J5 OR13A1 OR5F1	2.04e-07	541	158	14	14983052
Pubmed	Up-regulation and increased phosphorylation of protein kinase C (PKC) delta, mu and theta in the degenerating rd1 mouse retina.	PDE6B PRKCD PRKD1	3.67e-07	4	158	3	16503160
Pubmed	Differential regulation of PKD isoforms in oxidative stress conditions through phosphorylation of a conserved Tyr in the P+1 loop.	ABL1 PRKCD PRKD1	3.67e-07	4	158	3	28428613
Pubmed	Profound defects in pupillary responses to light in TRPM-channel null mice: a role for TRPM channels in non-image-forming photoreception.	PDE6B TRPM3 TRPM1	3.67e-07	4	158	3	22211741
Pubmed	KIR/HLA ligand incompatibility in kidney transplantation.	KIR2DS2 KIR2DL2 KIR2DL3	3.67e-07	4	158	3	18091530
Pubmed	Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.	KIR2DS2 KIR2DL2 KIR2DL3	3.67e-07	4	158	3	16929347
Pubmed	Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.	IL10 KIR2DS2 KIR2DL2 KIR2DL3	5.38e-07	15	158	4	20207982
Pubmed	ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex.	ADAMTS3 ADAMTS2 VCAN LTBP1	5.38e-07	15	158	4	38871984
Pubmed	Association of killer cell immunoglobulin-like receptor genotypes with vascular arterial events and anticardiolipin antibodies in patients with lupus.	KIR2DS2 KIR2DL2 KIR2DL3	9.14e-07	5	158	3	18755860
Pubmed	Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	9.14e-07	5	158	3	16112031
Pubmed	Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.	KIR2DS2 KIR2DL2 KIR2DL3	1.82e-06	6	158	3	17882223
Pubmed	Protein kinase C [micro] is regulated by the multifunctional chaperon protein p32.	PRKCD PRKD1 YWHAQ	1.82e-06	6	158	3	10831594
Pubmed	The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.	EPHB2 CSNK1A1L CSNK1A1	3.18e-06	7	158	3	17686994
Pubmed	Identification of seventeen novel KIR variants: fourteen of them from two non-Caucasian donors.	KIR2DS2 KIR2DL2 KIR2DL3	3.18e-06	7	158	3	11169255
Pubmed	Myocardial Angiopoietin-1 Controls Atrial Chamber Morphogenesis by Spatiotemporal Degradation of Cardiac Jelly.	ADAMTS3 ADAMTS2 TIMP3 VCAN	4.06e-06	24	158	4	29791855
Pubmed	KIR haplotype content at the allele level in 77 Northern Irish families.	KIR2DS2 KIR2DL2 KIR2DL3	5.07e-06	8	158	3	17200871
Pubmed	NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.	KIR2DS2 KIR2DL2 KIR2DL3	5.07e-06	8	158	3	18681957
Pubmed	Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.	KIR2DS2 KIR2DL2 KIR2DL3	7.57e-06	9	158	3	7749980
Pubmed	Alternatively spliced forms of human killer inhibitory receptors.	KIR2DS2 KIR2DL2 KIR2DL3	7.57e-06	9	158	3	8662091
Pubmed	DEFOG: a practical scheme for deciphering families of genes.	OR8I2 OR10J3 OR10R2 OR10J1 OR1N2 OR1L8 OR6F1 OR5F1	7.79e-06	219	158	8	12213199
Pubmed	Immunogenetic characteristics of patients with autoimmune gastritis.	IL10 KIR2DS2 KIR2DL2 KIR2DL3	8.91e-06	29	158	4	20082482
Pubmed	Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.	KIR2DS2 KIR2DL2 KIR2DL3	1.08e-05	10	158	3	12559621
Pubmed	Sequence-specific recognition of a PxLPxI/L motif by an ankyrin repeat tumbler lock.	ABL1 HDAC3 YWHAQ	1.48e-05	11	158	3	22649097
Pubmed	Natural killer cells and immune surveillance.	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-05	11	158	3	18830515
Pubmed	[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].	KIR2DS2 KIR2DL2 KIR2DL3	1.48e-05	11	158	3	19664392
Pubmed	Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.	IL10 KIR2DS2 KIR2DL2 KIR2DL3	1.92e-05	35	158	4	19683555
Pubmed	HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.	IL10 PRKCD PRKD1	1.96e-05	12	158	3	11919157
Pubmed	Peli1 Modulates the Subcellular Localization and Activity of Mdmx.	CSNK1A1L CSNK1A1 YWHAQ	1.96e-05	12	158	3	29523541
Pubmed	Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.	KIR2DS2 KIR2DL2 KIR2DL3	1.96e-05	12	158	3	19936734
Pubmed	Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.	KIR2DS2 KIR2DL2 KIR2DL3	1.96e-05	12	158	3	19181658
Pubmed	Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.	KIR2DS2 KIR2DL2 KIR2DL3	1.96e-05	12	158	3	20371502
Pubmed	Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	25359276
Pubmed	Allelic polymorphism of KIR2DL2/2DL3 in a southern Chinese population.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	26423800
Pubmed	The Cdc14B phosphatase displays oncogenic activity mediated by the Ras-Mek signaling pathway.	CDC14C CDC14B	2.05e-05	2	158	2	21502810
Pubmed	Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	23354688
Pubmed	Tissue-specific distribution of mouse casein kinase I alpha mRNA.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	9522121
Pubmed	Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	36929849
Pubmed	Birth and rapid subcellular adaptation of a hominoid-specific CDC14 protein.	CDC14C CDC14B	2.05e-05	2	158	2	18547142
Pubmed	Tyrosine 311 is phosphorylated by c-Abl and promotes the apoptotic effect of PKCdelta in glioma cells.	ABL1 PRKCD	2.05e-05	2	158	2	17126298
Pubmed	Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins.	PRKD1 YWHAQ	2.05e-05	2	158	2	10092600
Pubmed	KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	27251940
Pubmed	Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	15248031
Pubmed	High prevalence of HHV8 infection and specific killer cell immunoglobulin-like receptors allotypes in Sardinian patients with type 2 diabetes mellitus.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	24122895
Pubmed	Class III β-Tubulin Expression Is of Value in Selecting nab -Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	35695793
Pubmed	RIC, a calmodulin-binding Ras-like GTPase.	RIT2 RIT1	2.05e-05	2	158	2	8918462
Pubmed	Exploring the role of casein kinase 1α splice variants across cancer cell lines.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	38852281
Pubmed	Casein kinase 1 alpha regulates chromosome congression and separation during mouse oocyte meiotic maturation and early embryo development.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	23690993
Pubmed	The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells.	F2RL1 TMPRSS2	2.05e-05	2	158	2	15537383
Pubmed	The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes.	KIR2DS2 KIR2DL3	2.05e-05	2	158	2	9497500
Pubmed	Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	35154153
Pubmed	Killer cell immunoglobulin receptor profile on CD4(+) CD28(-) T cells and their pathogenic role in non-dialysis-dependent and dialysis-dependent chronic kidney disease patients.	KIR2DS2 KIR2DL3	2.05e-05	2	158	2	25484131
Pubmed	The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia.	IL10 COMT	2.05e-05	2	158	2	33127070
Pubmed	Transient receptor potential melastatin 1 (TRPM1) is an ion-conducting plasma membrane channel inhibited by zinc ions.	TRPM3 TRPM1	2.05e-05	2	158	2	21278253
Pubmed	Fibulin-1c regulates transforming growth factor-β activation in pulmonary tissue fibrosis.	FBLN1 LTBP1	2.05e-05	2	158	2	31343988
Pubmed	Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.	TIMP3 LRP1	2.05e-05	2	158	2	23166318
Pubmed	KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	30689576
Pubmed	Drosophila glucome screening identifies Ck1alpha as a regulator of mammalian glucose metabolism.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	25994086
Pubmed	Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133.	PROM1 VCAN	2.05e-05	2	158	2	17185982
Pubmed	Killer cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft function.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	17445184
Pubmed	CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.	IL10 PROM1	2.05e-05	2	158	2	18497886
Pubmed	Increased frequencies of the killer immunoglobulin-like receptor genes KIR2DL2 and KIR2DS2 are associated with neuroblastoma.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	26202659
Pubmed	Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation.	EPHB2 CD79A	2.05e-05	2	158	2	20176802
Pubmed	Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells.	TIMP3 LRP1	2.05e-05	2	158	2	27610455
Pubmed	Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling.	PRKCD PRKD1	2.05e-05	2	158	2	15024053
Pubmed	Association of killer cell immunoglobulin-like receptors with scleroderma.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	15146426
Pubmed	Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	25636579
Pubmed	TMPRSS2, a novel membrane-anchored mediator in cancer pain.	F2RL1 TMPRSS2	2.05e-05	2	158	2	25734995
Pubmed	[Correlation analysis between killer cell immunoglobulin-like receptor gene polymorphism and primary biliary cirrhosis].	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	25575065
Pubmed	Aldehyde oxidase 1 promoted the occurrence and development of colorectal cancer by up-regulation of expression of CD133.	AOX1 PROM1	2.05e-05	2	158	2	32470878
Pubmed	KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	22836042
Pubmed	Overexpression of CDC14B causes mitotic arrest and inhibits zygotic genome activation in mouse preimplantation embryos.	CDC14C CDC14B	2.05e-05	2	158	2	19923902
Pubmed	Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	33846289
Pubmed	Expression of KIR2DL3 and KIR2DS2 natural killer receptors in exercise.	KIR2DS2 KIR2DL3	2.05e-05	2	158	2	21165439
Pubmed	Identification of four novel KIR2DL2 alleles and two novel KIR2DL3 alleles in an East African population.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	20875478
Pubmed	Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.	ABL1 LTBP1	2.05e-05	2	158	2	25527259
Pubmed	Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	32961633
Pubmed	CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	37723657
Pubmed	Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-κB activation.	CD79A MAP3K7	2.05e-05	2	158	2	24833394
Pubmed	Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	23686481
Pubmed	Characterization of copine VII, a new member of the copine family, and its exclusion as a candidate in sporadic breast cancers with loss of heterozygosity at 16q24.3.	CPNE1 CPNE7	2.05e-05	2	158	2	10534407
Pubmed	Deacetylase activity of histone deacetylase 3 is required for productive VDJ recombination and B-cell development.	HDAC3 CD79A	2.05e-05	2	158	2	28739911
Pubmed	Interaction between protein kinase C delta and the c-Abl tyrosine kinase in the cellular response to oxidative stress.	ABL1 PRKCD	2.05e-05	2	158	2	10713049
Pubmed	KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	27030405
Pubmed	Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	36542875
Pubmed	Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.	TIMP3 LRP1	2.05e-05	2	158	2	27476612
Pubmed	Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.	KIR2DS2 KIR2DL3	2.05e-05	2	158	2	18158964
Pubmed	The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms.	KIR2DS2 KIR2DL2	2.05e-05	2	158	2	22024796
Pubmed	Prominin 1 is crucial for the early development of photoreceptor outer segments.	PDE6B PROM1	2.05e-05	2	158	2	38714794
Pubmed	PKD Phosphorylation as Novel Pathway of KV11.1 Regulation.	KCNH2 PRKD1	2.05e-05	2	158	2	29949809
Pubmed	The Transmembrane Protease Serine 2 (TMPRSS2) Non-Protease Domains Regulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike-Mediated Virus Entry.	ABL1 TMPRSS2	2.05e-05	2	158	2	37896901
Pubmed	Differential association of gene content polymorphisms of killer cell immunoglobulin-like receptors with placental malaria in HIV- and HIV+ mothers.	KIR2DL2 KIR2DL3	2.05e-05	2	158	2	22715396
Pubmed	Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	34216174
Pubmed	Casein Kinase 1α as a Novel Factor Affects Thyrotropin Synthesis via PKC/ERK/CREB Signaling.	CSNK1A1L CSNK1A1	2.05e-05	2	158	2	37108197
Pubmed	Sestrins induce natural killer function in senescent-like CD8+ T cells.	SESN3 SESN1	2.05e-05	2	158	2	32231301
Pubmed	KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.	KIR2DS2 KIR2DL2 KIR2DL3	2.54e-05	13	158	3	19934297
Pubmed	Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.	KIR2DS2 KIR2DL2 KIR2DL3	2.54e-05	13	158	3	19120281
Cytoband	19q13.4	KIR2DS2 DNAAF3 KIR2DL2 KIR2DL3	1.66e-04	79	158	4	19q13.4
Cytoband	1q23.2	OR10J3 OR10J1 OR10J5	2.41e-04	35	158	3	1q23.2
Cytoband	1q44	AHCTF1 OR2T10 OR2T11 OR6F1	5.87e-04	110	158	4	1q44
Cytoband	Ensembl 112 genes in cytogenetic band chr1q44	AHCTF1 OR2T10 OR2T11 OR6F1	1.03e-03	128	158	4	chr1q44
Cytoband	11q22.1	CNTN5 ANGPTL5	1.04e-03	14	158	2	11q22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1q23	OR10J3 DDR2 OR10R2 OR10J1 OR10J5	1.16e-03	226	158	5	chr1q23
GeneFamily	CD molecules\|Killer cell immunoglobulin like receptors	KIR2DS2 KIR2DL2 KIR2DL3	2.62e-04	18	128	3	620
Coexpression	GSE13411_NAIVE_VS_MEMORY_BCELL_DN	BHLHE41 IARS1 BDH1 TBC1D9 NIT2 HDAC3 HOXD12 BTBD7 CPNE1 PRKCD	3.06e-07	198	155	10	M3246
Coexpression	GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP	COMT AHCTF1 DDR2 SESN1 MLYCD MRPS2 PI4KA HPF1 PRKCD	2.90e-06	198	155	9	M4096
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP	FBLN1 CSNK1A1L CSNK1A1	6.98e-06	7	155	3	MM567
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	MRC1 DVL3 BRINP1 BCL2A1 DNAH7 PTPN9 CSNK1A1 VCAN	2.54e-05	199	155	8	M5235
Coexpression	GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP	USP22 TTC3 BDH1 B4GALT6 RIT1 METTL9 KCNH2 KIR2DL3	2.64e-05	200	155	8	M8968
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 AOX1 LAMB1 SLC16A12 SVEP1 FBLN1 TIMP3 PRKD1 LTBP1 ANO3 HMGCLL1	9.32e-11	192	157	11	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	ADAMTS2 DDR2 AOX1 LAMB1 SLC16A12 SVEP1 TIMP3 PRKD1 LTBP1 ANO3 HMGCLL1	1.10e-10	195	157	11	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 HMGCLL1	1.44e-10	200	157	11	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 HMGCLL1	1.44e-10	200	157	11	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 ANGPTL5	7.40e-10	176	157	10	2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b
ToppCell	343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 ANGPTL5	7.40e-10	176	157	10	f33ab41d121b59d871ad7d48ca021524a027d2ef
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 AOX1 LAMB1 SLC16A12 SVEP1 FBLN1 TIMP3 PRKD1 ANO3 HMGCLL1	1.64e-09	191	157	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 ADAMTS2 DDR2 AOX1 LAMB1 SLC16A12 SVEP1 FBLN1 LRP1 PRKD1	1.90e-09	194	157	10	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADAMTS3 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 PRKD1 LTBP1	2.43e-09	199	157	10	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAMTS3 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 PRKD1 LTBP1	2.55e-09	200	157	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	2.55e-09	200	157	10	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	2.55e-09	200	157	10	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 HMGCLL1	2.55e-09	200	157	10	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ADAMTS3 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 PRKD1 LTBP1	2.55e-09	200	157	10	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1 HMGCLL1	2.55e-09	200	157	10	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 HMGCLL1	2.55e-09	200	157	10	3dd022e974fec7013ba18f333da63f58fbf2dd7c
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 ADAMTS3 ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 LRP1 HMGCLL1	2.07e-08	185	157	9	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ADAMTS2 LAMB1 SLC16A12 SVEP1 FBLN1 TIMP3 PRKD1 ANO3 HMGCLL1	2.27e-08	187	157	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 DDR2 AOX1 LAMB1 SLC16A12 SVEP1 FBLN1 LRP1 PRKD1	2.49e-08	189	157	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LTBP1	2.61e-08	190	157	9	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 PRKD1	2.73e-08	191	157	9	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 ABLIM1 FBLN1 VCAN LRP1 LTBP1	2.86e-08	192	157	9	321850b0f881420c2d57d3e825e365c82fa511ab
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 ABLIM1 FBLN1 VCAN LRP1 LTBP1	2.86e-08	192	157	9	cf2765d8bc074f7f9ee864eae632a3b705175842
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 LRP1 PRKD1	2.86e-08	192	157	9	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 LRP1 PRKD1	2.99e-08	193	157	9	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS2 AOX1 LAMB1 SLC16A12 SVEP1 FBLN1 TIMP3 PRKD1 HMGCLL1	3.12e-08	194	157	9	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-mesenchymal_progenitor_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 ABLIM1 FBLN1 TIMP3 VCAN LRP1 LTBP1	3.12e-08	194	157	9	3d25d6ebec8d1b6001f602257cd15b3ba04cf0c1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 LRP1 PRKD1	3.12e-08	194	157	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 ABLIM1 FBLN1 TIMP3 VCAN LRP1 LTBP1	3.12e-08	194	157	9	ff19fb5bc7feae3e774ef4ab720beb9dec219f45
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 ANGPTL5	3.26e-08	195	157	9	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1 HMGCLL1	3.41e-08	196	157	9	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1 HMGCLL1	3.72e-08	198	157	9	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DDR2 AOX1 LAMB1 SVEP1 FBLN1 DHCR7 VCAN LRP1 LTBP1	3.89e-08	199	157	9	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	4.06e-08	200	157	9	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1 ANGPTL5	4.06e-08	200	157	9	9dd2eb70c1cc146935f5aff27373dfc65cb8c098
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1	4.06e-08	200	157	9	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1	4.06e-08	200	157	9	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1	4.06e-08	200	157	9	10f0c20ba7c71d9e2e177597f85b41cb40f0d878
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.06e-08	200	157	9	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	RASGRF2 ADAMTS2 DDR2 LAMB1 SVEP1 TIMP3 VCAN LRP1	2.37e-07	178	157	8	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	PRTG TOX ADAMTS3 IARS1 DOCK9 BTBD9 NRXN3 PRKD1	3.60e-07	188	157	8	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	ADAMTS3 DDR2 AOX1 SVEP1 FBLN1 VCAN LRP1 LTBP1	3.60e-07	188	157	8	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 DDR2 AOX1 LAMB1 SVEP1 FBLN1 LRP1 PRKD1	3.74e-07	189	157	8	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	3.74e-07	189	157	8	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	3.90e-07	190	157	8	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1	3.90e-07	190	157	8	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	3.90e-07	190	157	8	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 VCAN LRP1 ANO3 HMGCLL1	4.06e-07	191	157	8	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 VCAN LRP1 ANO3 HMGCLL1	4.06e-07	191	157	8	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.06e-07	191	157	8	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 VCAN LRP1 ANO3 HMGCLL1	4.22e-07	192	157	8	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	4.22e-07	192	157	8	7b48df661f61ce494bf6f0b9a74b0422e29c24bf
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 SVEP1 HSD3B7 FBLN1 VCAN LRP1	4.22e-07	192	157	8	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 VCAN LRP1 LTBP1 ANO3	4.22e-07	192	157	8	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1	4.22e-07	192	157	8	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	4.22e-07	192	157	8	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS3 ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 LRP1 PRKD1	4.22e-07	192	157	8	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	4.39e-07	193	157	8	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.39e-07	193	157	8	25248b8e65d558b1a96a87c93e3e5b4c0ba168fe
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 PRKD1 HMGCLL1	4.39e-07	193	157	8	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.39e-07	193	157	8	f1f1097204e07a7bed416425b8256942038a734f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.56e-07	194	157	8	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.56e-07	194	157	8	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.75e-07	195	157	8	773728703bc8969bff0e1de58fe3e1631add0a0a
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1 PRKD1	4.75e-07	195	157	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.75e-07	195	157	8	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.75e-07	195	157	8	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	facs-Trachea-18m-Mesenchymal\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.75e-07	195	157	8	0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.93e-07	196	157	8	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	4.93e-07	196	157	8	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1	4.93e-07	196	157	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 FBLN1 CSGALNACT2 VCAN LRP1 LTBP1	4.93e-07	196	157	8	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTS2 DDR2 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	4.93e-07	196	157	8	d4676a6b0d9e417795fc9a6bcb1762d3dd656ca9
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 FBLN1 CSGALNACT2 VCAN LRP1 LTBP1	4.93e-07	196	157	8	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	RA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADAMTS2 DDR2 AOX1 FBLN1 TIMP3 VCAN PRKD1 ANO3	4.93e-07	196	157	8	e8cbda03837f1f26470a9d93aa7fdaa04e08e38a
ToppCell	facs-Heart-LA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 DDR2 LAMB1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.13e-07	197	157	8	2a91738cb6d7588869dd00deeea0cbbc2d6aa34d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1	5.13e-07	197	157	8	71786e9432e2d649f5d86f639abb25e7102deb67
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.13e-07	197	157	8	4cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 SVEP1 FBLN1 NRXN3 TIMP3 LTBP1 ANO3	5.13e-07	197	157	8	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	RASGRF2 LAMB1 FBLN1 CSGALNACT2 VCAN PRKD1 LTBP1 HMGCLL1	5.13e-07	197	157	8	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	ADAMTS2 DDR2 LAMB1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.33e-07	198	157	8	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1	5.33e-07	198	157	8	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN PRKD1	5.33e-07	198	157	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	5.53e-07	199	157	8	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DDR2 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.53e-07	199	157	8	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	ILEUM-inflamed-(8)_Fibroblast\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ADAMTS2 DDR2 LAMB1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.53e-07	199	157	8	cb3c04b91c8e8080137823b11c76ca0a2adda52d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	5.53e-07	199	157	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ADAMTS2 DDR2 LAMB1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.53e-07	199	157	8	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1	5.53e-07	199	157	8	9672230aa0bc6a7289050c955f5154ca183a5159
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1	5.53e-07	199	157	8	e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	DDR2 AOX1 LAMB1 SVEP1 FBLN1 VCAN LRP1 LTBP1	5.53e-07	199	157	8	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1	5.75e-07	200	157	8	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR2 AOX1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1 ANGPTL5	5.75e-07	200	157	8	17ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 LAMB1 SVEP1 FBLN1 TIMP3 VCAN LRP1 HMGCLL1	5.75e-07	200	157	8	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDR2 AOX1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1 ANGPTL5	5.75e-07	200	157	8	665df8391d2ebcfc6536318612f4992852b5e2b8
ToppCell	Parenchymal-10x3prime_v2-Stromal\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LRP1 LTBP1	5.75e-07	200	157	8	f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCell	Skin-Fibroblasts\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	ADAMTS2 DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1	5.75e-07	200	157	8	f777eadf571a1a6d246da87346a9cb9d511c2e81
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS2 DDR2 AOX1 LAMB1 SVEP1 FBLN1 TIMP3 LTBP1	5.75e-07	200	157	8	6316c288022719b9e6c4332c5cb9041e1188d0e8
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABL1 DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1	5.75e-07	200	157	8	a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed
ToppCell	Fibroblast\|World / shred by cell class for parenchyma	DDR2 AOX1 SVEP1 FBLN1 TIMP3 VCAN LRP1 LTBP1	5.75e-07	200	157	8	dec9ce1bc2571197003596f32e5f742ede72aa79
Disease	Disorder of eye	PDE6B PROM1 TIMP3 VCAN SLC45A2 TRPM1 USH2A	1.30e-04	212	154	7	C0015397
Disease	nephrotic syndrome type 20 (implicated_via_orthology)	TBC1D9B TBC1D9	1.61e-04	4	154	2	DOID:0070357 (implicated_via_orthology)
Disease	monocyte chemotactic protein-2 measurement	PROM1 CNTN5	1.61e-04	4	154	2	EFO_0010789
Disease	Schizophrenia	IL10 CACNA1B COMT ADAMTS3 BTBD9 HDAC3 NRXN3 SLC18A1 KCNH2 PI4KA LRP1 TRPM1 MSS51 ALK	2.29e-04	883	154	14	C0036341
Disease	mastiha supplement exposure measurement, blood glutathione peroxidase measurement	SLC24A4 LSS	2.68e-04	5	154	2	EFO_0600067, EFO_0600071
Disease	axial length measurement, refractive error	RASGRF2 CNTN5	4.00e-04	6	154	2	EFO_0005318, MONDO_0004892
Disease	oral squamous cell carcinoma (is_implicated_in)	IL10 ABL1 DDR2	4.15e-04	28	154	3	DOID:0050866 (is_implicated_in)
Disease	skin pigmentation	ADAMTS2 SLC24A4 SLC45A2 MAP3K7	4.74e-04	69	154	4	EFO_0003784
Disease	syndromic X-linked intellectual disability Najm type (implicated_via_orthology)	CSNK1A1L CSNK1A1	5.59e-04	7	154	2	DOID:0060807 (implicated_via_orthology)
Disease	MASA syndrome (implicated_via_orthology)	TRPM3 TRPM1	5.59e-04	7	154	2	DOID:0060246 (implicated_via_orthology)
Disease	methylcobalamin deficiency type cblE	SEZ6L2 ABLIM1 NRXN3 ASB7	6.18e-04	74	154	4	MONDO_0009354
Disease	corneal resistance factor	PRTG ABL1 ADAMTS2 DDR2 MTMR10 CSGALNACT2 TRPM3 VCAN LTBP1	6.32e-04	451	154	9	EFO_0010067
Disease	metastasis measurement, disease progression measurement	RIT2 CNTN5 MAP3K7	7.41e-04	34	154	3	EFO_0007675, EFO_0008336
Disease	amino acid measurement	EPHB2 LAMB1 DNAH7 MLYCD CD6 VCAN CNTN5 TMPRSS2 LTBP1 MAP3K7 ALK	9.01e-04	678	154	11	EFO_0005134
Disease	cataract (implicated_via_orthology)	TRPM3 SLC45A2 LSS	1.03e-03	38	154	3	DOID:83 (implicated_via_orthology)
Disease	pigmentation disease (is_implicated_in)	SLC24A4 SLC45A2	1.44e-03	11	154	2	DOID:10123 (is_implicated_in)
Disease	endometriosis (implicated_via_orthology)	IL10 HDAC3	1.44e-03	11	154	2	DOID:289 (implicated_via_orthology)
Disease	Night blindness, congenital stationary, type 1	PDE6B TRPM1	1.73e-03	12	154	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	PDE6B TRPM1	1.73e-03	12	154	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	PDE6B TRPM1	1.73e-03	12	154	2	C1864877
Disease	hair colour measurement, hair morphology measurement	SLC24A4 SLC45A2	1.73e-03	12	154	2	EFO_0007821, EFO_0007822
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	PDE6B TRPM1	1.73e-03	12	154	2	C1850362
Disease	X-Linked Csnb	PDE6B TRPM1	1.73e-03	12	154	2	C3711543
Disease	esophageal cancer (is_marker_for)	IL10 BHLHE41	1.73e-03	12	154	2	DOID:5041 (is_marker_for)
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	PDE6B TRPM1	1.73e-03	12	154	2	C1848172
Disease	Alzheimer disease, cognitive decline measurement, Cognitive impairment	RAB20 BDH1	2.03e-03	13	154	2	EFO_0007710, HP_0100543, MONDO_0004975
Disease	Cone-rod synaptic disorder, congenital nonprogressive	PDE6B TRPM1	2.03e-03	13	154	2	C4041558
Disease	suntan	SLC24A4 CPNE1 SLC45A2 CPNE7	2.11e-03	103	154	4	EFO_0004279
Disease	inositol measurement	RIT2 TRPM3	2.36e-03	14	154	2	EFO_0010504
Disease	FEV change measurement, response to corticosteroid	CYSLTR2 MAP3K7	2.36e-03	14	154	2	EFO_0005921, GO_0031960
Disease	interferon gamma measurement	EPHB2 CYSLTR2 DNAAF3	2.42e-03	51	154	3	EFO_0008165
Disease	body weight	CACNA1B COPB1 ADAMTS3 ATP13A5 BRINP1 RIT2 PTPN9 NRXN3 SLC24A4 KCNH2 FRRS1L PRKD1 LTBP1 YWHAQ MAP3K7	2.55e-03	1261	154	15	EFO_0004338
Disease	Autistic Disorder	IL10 COMT LAMB1 SEZ6L2 NRXN3 DHCR7	2.55e-03	261	154	6	C0004352
Disease	skin aging measurement	METTL15P1 MBOAT2 SLC24A4 SLC45A2 PRKD1	2.66e-03	181	154	5	EFO_0008006
Disease	amyotrophic lateral sclerosis, age at onset	NRXN3 SLC18A1	2.72e-03	15	154	2	EFO_0004847, MONDO_0004976
Disease	growth-regulated alpha protein measurement	OR10J3 OR10J1 OR10J5	3.00e-03	55	154	3	EFO_0008146
Disease	colorectal mucinous adenocarcinoma	RASGRF2 TRPM1	3.10e-03	16	154	2	EFO_0009361
Disease	phosphatidylcholine 38:6 measurement	AHCTF1 LTBP1	3.10e-03	16	154	2	EFO_0010388
Disease	lifestyle measurement, alcohol consumption measurement	BRINP1 OR10J1 ASB7 PRKD1	3.15e-03	115	154	4	EFO_0007878, EFO_0010724
Disease	sleep apnea measurement	BTBD9 ENTPD4 TRPM3 SLC45A2	3.25e-03	116	154	4	EFO_0007817
Disease	Night blindness, congenital stationary	PDE6B TRPM1	3.50e-03	17	154	2	C0339535
Disease	alpha-L-iduronidase measurement	PDE6B FGFRL1	3.50e-03	17	154	2	EFO_0020139
Disease	chromosomal aberration frequency	COPB1 OR10J5	3.92e-03	18	154	2	EFO_0009860
Disease	Febrile seizure (within the age range of 3 months to 6 years)	IL10 ANO3	3.92e-03	18	154	2	HP_0002373
Disease	body fat distribution	ADAMTS3 ADAMTS2 SEZ6L2 KCNH2 VCAN	4.25e-03	202	154	5	EFO_0004341
Disease	unipolar depression, bipolar disorder, schizophrenia	ADAMTS2 METTL9	4.83e-03	20	154	2	EFO_0003761, MONDO_0004985, MONDO_0005090
Disease	Malignant neoplasm of prostate	EPHB2 IL10 COMT AOX1 SESN3 FBLN1 TMPRSS2 VAV3 MAP3K7	5.19e-03	616	154	9	C0376358

Protein segments in the cluster

Peptide	Gene	Start	Entry
MKGDYFRYLAEVACG	YWHAQ	121	P27348
CLEYYAGLAASMAGE	ALDH9A1	116	P49189
EEFQKLNYYVGMCGD	ATP13A5	836	Q4VNC0
MEYAGRQYYLGDKCQ	ALG13	486	Q9NP73
DVLCARMLYNYGADT	ASB7	226	Q9H672
LASDAGLYRCDVMYG	VCAN	121	P13611
NGEYLCTLDYQRMYG	ABLIM1	141	O14639
ALSYIMCNGEGEYLC	BRINP1	246	O60477
EAFSDCLRYEMYPLG	BDH1	216	Q02338
HRDFIGLDYSSLYMC	BHLHE41	16	Q9C0J9
NAAFLVGCYMVIYLG	CDC14B	131	O60729
EQRATLMGGQVYFCY	HSD3B7	246	Q9H2F3
CYSERAMLYYELEDG	ABCG8	471	Q9H221
MTDCEFGYIYRLAQD	BCL2A1	1	Q16548
SYPFEVMCDMDYRGG	ANGPTL5	176	Q86XS5
IFESCGYEANYLGSM	ANKS1A	936	Q92625
RDCYDMAALLINYGA	ASB14	161	A6NK59
CSMYEDISRGLQGTY	CD79A	196	P11912
FNYVGDLMGSLAYCL	DHCR7	406	Q9UBM7
YYIFGDLCGNMANLS	DVL3	491	Q92997
YDPAACGRISYNDMF	CACNA1B	1736	Q00975
NAAFLVGCYMVIYLG	CDC14C	101	A4D256
YSMNEQCRFDFGLGY	ADAMTS2	486	O95450
ELGMGKSGYCRYRDY	ANO3	876	Q9BYT9
LSAVGYFRGYESDMN	AOX1	1136	Q06278
SDAGMYQCLAENKYG	CNTN5	451	O94779
GALYMFYALAIVCDD	SLC24A4	106	Q8NFF2
GSMYCRGAAAIILTY	RAB20	66	Q9NX57
FCNPSRLMTGEDGYY	RABGEF1	341	Q9UJ41
RLMTGEDGYYFTNLC	RABGEF1	346	Q9UJ41
MQDLAGTYRCYGSVT	KIR2DS2	91	P43631
RNGLVFIYDMCGSNY	PTPN9	146	P43378
LELGMDLFCYGSHYF	HPF1	291	Q9NWY4
SLSGRMYYSCNGEEL	CD6	321	P30203
ECFLLGSMAYNRYIA	OR8I2	111	Q8N0Y5
FCGDYGMIDESIYFS	CT55	46	Q8WUE5
MQDLAGTYRCYGSVT	KIR2DL2	91	P43627
ECGFYGMYDKILLFR	PRKD1	91	Q15139
GLELGMDLFCYGSHY	nan	291	A8MVJ9
EYLSYNCNFMGILAG	MBOAT2	176	Q6ZWT7
GYLGCQALSEMIQFY	IL10	76	P22301
MQDLAGTYRCYGSVT	KIR2DL3	91	P43628
YYIMFLGSSCQLDNR	MSS51	436	Q4VC12
ACYGELGQSRMYFNA	MTMR10	706	Q9NXD2
ELYRATFYAAEIMCG	PRKCD	446	Q05655
IADFGMSRNLYSGDY	DDR2	726	Q16832
DEVIMGYNCTIFAYG	KIF11	91	P52732
MLAEDGASCREYAGY	LRP1	2186	Q07954
RYSEYGAAVLFLLMC	KCNH2	541	Q12809
GSCGLMANYRYFLEE	MLYCD	446	O95822
CVDLDRMFVISYYLG	EFHC2	446	Q5JST6
YGGCMSLIAVRVFYR	EPHB2	181	P29323
YICLGANTMGYSFRS	FGFRL1	336	Q8N441
VGAFRCEYCDSGYRM	LTBP1	976	Q14766
AYLNCERYSVGLLDM	PDE6B	266	P35913
GYCGFMAANLYARSI	COPB1	886	P53618
CLVMEYAEGGSLYNV	MAP3K7	101	O43318
FGLEAFACMGQTYRD	LSS	591	P48449
AMLNYGYVGCIRDLF	NRXN3	601	Q9Y4C0
DQLGRQTDFGMYDYF	PI4KA	1906	P42356
TRLPYLCEGDMYNDY	METTL9	291	Q9H1A3
AVYDMVVRGNCFCYG	LAMB1	261	P07942
MDGGRNISSLCYLYT	METTL15P1	196	P0C7V9
FAMYLNYCRGLRFEE	CSNK1A1L	256	Q8N752
MYEVGAESGRYYCLN	HDAC3	206	O15379
MYFYLQLGGAECCLL	OR2T10	101	Q8NGZ9
SDEGFYQCLAMNKYG	PRTG	106	Q2VWP7
RLYTGIQCYSCGMRF	PCF11	1336	O94913
ALCNVLIGFFYGNMY	F2RL1	146	P55085
TGYYFDGISRMCVDV	FBLN1	386	P23142
IRCFGFDMDYTLAAY	NT5DC4	16	Q86YG4
GAYCGYSAVRMARLL	COMT	116	P21964
FLCAYAVGMYLSGII	SLC37A1	106	P57057
YSMDEQCRFDFGVGY	ADAMTS3	476	O15072
CQYRSDFLTIGGFDM	CSGALNACT2	436	Q8N6G5
GSAMELCGNDSVYAY	SLC2A11	281	Q9BYW1
TFYEGRADMCAALCY	DOCK9	1466	Q9BZ29
YNGRFQLLYVACGMV	DNAAF3	376	Q8N9W5
DRNYYGCGEMPRHFA	B4GALT6	236	Q9UBX8
AETCDYFLSYRMIGA	FRRS1L	116	Q9P0K9
HRVYSFLDYIMGGCQ	CPNE7	366	Q9UBL6
EALRYMTGECNYGGR	DNAH7	3631	Q8WXX0
MCERSLYRAGYVGSL	HOXD12	1	P35452
EFMTYGNLLDYLREC	ABL1	316	P00519
YLYTGEFGMEDSRFQ	BTBD7	201	Q9P203
FTGDGDYQFDIYRLM	HASPIN	711	Q8TF76
LGMCFGDRYYREPFV	GPR161	336	Q8N6U8
YCEERYTLDLTGGMF	AHCTF1	326	Q8WYP5
ARCQYFRALLYGGMR	BTBD9	56	Q96Q07
SSLYMEYEGGRYLCS	RUBCN	446	Q92622
AMFGREFCYAVEAAY	SLC45A2	41	Q9UMX9
EYSFLDYVMGGCQIN	CPNE1	271	Q99829
TNCFLLTAMGYDRYV	OR10J1	121	P30954
GSEFFLLGLMAYDCY	OR2T11	106	Q8NH01
EESSISYGGCMAQLY	OR13A1	106	Q8NGR1
ECILFGLMAYDRYAA	OR5F1	111	O95221
SLGCTEYFLLAAMAY	OR6F1	106	Q8NGZ6
NNCFLLTVMGYDRYV	OR10J3	111	Q5JRS4
NCFLLTAMGYDRYVA	OR10J5	111	Q8NHC4
AGCLTQMYFLYALGN	OR1L8	96	Q8NGR8
GLDNCLLAVMAYDRY	OR1N2	126	Q8NGR9
NCLLLGVMGYDRYAA	OR10R2	131	Q8NGX6
ITGNFGLMYLIYCDE	OR52N1	41	Q8NH53
DNLCSRGYEAMYTLL	MRC1	146	P22897
YYRGDRNAMCGLEER	GPR132	271	Q9UNW8
RLYGMGCYEISLGDT	HMGCLL1	236	Q8TB92
ANGIITQYCLYMDGR	USH2A	2081	O75445
TQYCLYMDGRLIYSG	USH2A	2086	O75445
MVGGLDRYFQVARCY	DARS2	251	Q6PI48
CMFGIRYDDYDYGEI	SESN1	411	Q9Y6P5
GLMNGVRFYCYSLAC	SLC25A34	81	Q6PIV7
DFSFYICGLLYMIGI	SLC16A14	471	Q7RTX9
VCYLFAVGMDGLCYL	SLC16A12	351	Q6ZSM3
LFYFEGEQSCRPAGM	RASGRF2	51	O14827
EQYMRGGEGFIICYS	RIT2	86	Q99578
QRRYDMYNTACFLGE	SAMD9L	1186	Q8IVG5
YMAEGERLYLCGEFS	ODAD4	16	Q96NG3
FAMYLNYCRGLRFEE	CSNK1A1	256	P48729
YCTEDVLRMGGDYNA	ENTPD4	436	Q9Y227
CYRTLYIGTGADMDV	PHF12	811	Q96QT6
FAACGIDRMNYDSYL	PROM1	621	O43490
GICYDMRFAELAQIY	NIT2	151	Q9NQR4
PYFGAEDYRVCMDFN	IARS1	326	P41252
GYSLEGAAMLTCYSR	SEZ6L2	736	Q6UXD5
GFVDAECYVLAAMAY	OR5AR1	106	Q8NGP9
ECYVLAAMAYGRFVA	OR5AR1	111	Q8NGP9
FSYLIENMARDCGEY	MRPS2	151	Q9Y399
CNNGYYLLGDSRMFC	SVEP1	1716	Q4LDE5
SCYSGYMLEGFLRSV	SVEP1	3441	Q4LDE5
MASYLYGVLFAVGLC	SERPINA9	1	Q86WD7
FFEYGRGVCMYRTAK	TBC1D9B	486	Q66K14
DIYRASYYRKGGCAM	ALK	1276	Q9UM73
FMSDCYLGLDQQYDI	ASCC3	2161	Q8N3C0
FGDLACRIMSYSLYV	CYSLTR2	106	Q9NS75
LSCCFVYHMYRERGG	AGTRAP	101	Q6RW13
GRDDMKADCILYYGF	RECQL	406	P46063
EYCMEEGGLYYCQAR	TECTA	1081	O75443
LAIDLMYGGIYCFLC	USP22	101	Q9UPT9
EREICMYSSFQYRGG	ZSWIM5	106	Q9P217
GRAACRDMGYKNNFY	TMPRSS2	181	O15393
RCSMKGEAIGNYYIN	TRDV2	41	A0JD36
ADCLYNLGLCYMEEG	TTC6	101	Q86TZ1
PCFLDAYVGRGNSYM	TTC6	241	Q86TZ1
YASRGVCFRGESCMY	MKRN3	246	Q13064
RDQYMRAGEGFIICY	RIT1	86	Q92963
CSGRHYCLRGMDYYA	SMRP1	201	Q8NCR6
CMFGIRYDDYDYGEV	SESN3	411	P58005
VIEYLMGGAYRCNYT	TRPM3	586	Q9HCF6
IHFAEYGQGICMYRT	TBC1D9	491	Q6ZT07
YECGQCGRYFIQMAD	ZNF620	196	Q6ZNG0
GHYRYCDALSMLGEY	TTC3	301	P53804
YISREMCNSERSYGG	TMPRSS12	231	Q86WS5
GLYYGVLERDFAEMC	RNF121	186	Q9H920
YLLRGYRMLGETCAD	ZNRD2	41	O60232
VLEYLMGGAYRCNYT	TRPM1	536	Q7Z4N2
DGLTYYNRCYMDAEA	WFIKKN1	131	Q96NZ8
YIFEGALGMSNRDSY	VMA21	51	Q3ZAQ7
QGNSLLCSYGMDDYV	WDR87	481	Q6ZQQ6
YCSSGGMQRDKALYL	TOX	511	O94900
NSVYLVMEYCNGGDL	ULK1	86	O75385
CGLSYYMGQHCFIRE	USP32	36	Q8NFA0
GRVYDGKMYTGLCNF	TIMP3	106	P35625
MFCAGYMEGIYDACR	TMPRSS11A	351	Q6ZMR5
YGSVYAIADVAFCMG	SLC18A1	426	P54219
QMLLRGTFYQGYLCF	VAV3	531	Q9UKW4